LTI
Laffer Tengler Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11
| Closed | -$11.6K | – | 314 |
|
|
2024
Q2 | $11.6K | Hold |
11
| – | – | ﹤0.01% | 307 |
|
|
2024
Q1 | $10.6K | Hold |
11
| – | – | ﹤0.01% | 299 |
|
|
2023
Q4 | $9.66K | Hold |
11
| – | – | ﹤0.01% | 272 |
|
|
2023
Q3 | $9.05K | Sell |
11
-2,443
| -100% | -$2.01M | ﹤0.01% | 281 |
|
|
2023
Q2 | $1.76M | Sell |
2,454
-52
| -2% | -$37.4K | 0.47% | 73 |
|
|
2023
Q1 | $2.06M | Buy |
2,506
+86
| +4% | +$70.7K | 0.56% | 68 |
|
|
2022
Q4 | $1.75M | Buy |
2,420
+90
| +4% | +$64.9K | 0.5% | 66 |
|
|
2022
Q3 | $1.61M | Buy |
2,330
+43
| +2% | +$29.6K | 0.59% | 69 |
|
|
2022
Q2 | $1.35M | Sell |
2,287
-43
| -2% | -$25.4K | 0.47% | 82 |
|
|
2022
Q1 | $1.63M | Sell |
2,330
-43
| -2% | -$30K | 0.49% | 81 |
|
|
2021
Q4 | $1.5M | Buy |
2,373
+266
| +13% | +$168K | 0.43% | 89 |
|
|
2021
Q3 | $1.28M | Buy |
2,107
+411
| +24% | +$249K | 0.37% | 103 |
|
|
2021
Q2 | $947K | Buy |
1,696
+1,269
| +297% | +$709K | 0.36% | 93 |
|
|
2021
Q1 | $202K | Buy |
427
+47
| +12% | +$22.2K | 0.08% | 154 |
|
|
2020
Q4 | $182K | Buy |
+380
| New | +$182K | 0.08% | 160 |
|
|
2016
Q2 | – | Sell |
-4,353
| Closed | -$1.57M | – | 258 |
|
|
2016
Q1 | $1.57M | Buy |
+4,353
| New | +$1.57M | 0.42% | 111 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 42 |
|
|
2015
Q3 | – | Sell |
-4,353
| Closed | -$2.22M | – | 48 |
|
|
2015
Q2 | $2.22M | Buy |
+4,353
| New | +$2.22M | 0.54% | 42 |
|